US Patent Issued to MannKind on May 20 for "Use of ultrarapid acting insulin" (Pennsylvania, New Jersey, Connecticut, California Inventors)

ALEXANDRIA, Va., June 16 -- United States Patent no. 12,303,554, issued on May 20, was assigned to MannKind Corp. (Danbury, Conn.).

"Use of ultrarapid acting insulin" was invented by Anders Hasager Boss (Princeton, N.J.), Richard Petrucci (New Canaan, Conn.), Campbell Howard (Yardley, Pa.) and Alfred Mann (Valencia, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are improved methods of treating hyperglycemia with a combination of an ultrarapid acting insulin and insulin glargine comprising prandial administration of the ultrarapid insulin, and administration of a first dose of insulin glargine within 6 hours of waking for a day."

The patent was filed on Dec. 8, 2022, under Applicatio...